Abstract

Starting with different drug administration methods, Here is a summary of medication delivery methods. (DDS). The descriptions of different medication formulations, drug delivery systems, and targeted drug delivery systems follow. Delivering proteins and peptides has unique difficulties. The delivery of drugs is thought to be improved by nanoparticles, which can be both pharmacological and diagnostic in nature. The advancement of personalised medicine, which encompasses pharmacogenomics, pharmacogenetics, and pharmacoproteomic, will be made easier by improvements in medication administration. The ideal DDS, commercial considerations, present successes, difficulties, and possibilities are also covered. The pharmaceutical active component can be released via the drug delivery method to produce the desired therapeutic effect. The low bioavailability and erratic plasma drug levels of conventional drug delivery methods (tablets, capsules, syrups, ointments, etc.) prevent them from delivering sustainable delivery. The entire therapy procedure may be ineffective without a reliable delivery mechanism. To achieve optimal efficacy and safety, the medicine must also be administered at a precisely regulated rate and at the intended spot. The issues with traditional medication delivery are addressed by the invention of controlled drug delivery systems. Over the last 20 years, controlled drug delivery systems have seen a significant change, progressing from large- and nanoscale to intelligent focused delivery. The first section of this study offers a fundamental overview of drug delivery methods with a focus on the medication's pharmacokinetics. It also talks bout the limits of traditional medication delivery methods. Drug delivery systems are also covered in detail, along with design factors, categories, and illustrations. Additionally, the use of stimuli-responsive and intelligence materials for targeted and smart medication administration is presented together with recent key discoveries. The obstacles and potential prospects for regulated medication distribution are discussed in the paper's conclusion

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call